0001493152-18-003516.txt : 20180316
0001493152-18-003516.hdr.sgml : 20180316
20180316171127
ACCESSION NUMBER: 0001493152-18-003516
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06c
FILED AS OF DATE: 20180316
DATE AS OF CHANGE: 20180316
EFFECTIVENESS DATE: 20180316
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROLUNG INC
CENTRAL INDEX KEY: 0001541884
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 201922768
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-307971
FILM NUMBER: 18696578
BUSINESS ADDRESS:
STREET 1: 757 EAST SOUTH TEMPLE, SUITE 150
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84102
BUSINESS PHONE: 801-204-9623
MAIL ADDRESS:
STREET 1: 757 EAST SOUTH TEMPLE, SUITE 150
CITY: SALT LAKE CITY
STATE: UT
ZIP: 84102
FORMER COMPANY:
FORMER CONFORMED NAME: FRESH MEDICAL LABORATORIES, INC.
DATE OF NAME CHANGE: 20120209
D
1
primary_doc.xml
X0708
D
LIVE
0001541884
PROLUNG INC
757 EAST SOUTH TEMPLE
SUITE 150
SALT LAKE CITY
UT
UTAH
84102
801-204-9623
DELAWARE
Fresh Medical Laboratories, Inc.
FRESH MEDICAL LABORATORIES, INC.
Corporation
true
Steven
C
Eror
757 East South Temple
Suite 150
Salt Lake City
UT
UTAH
84102
Executive Officer
Director
Michael
A
Garff
757 East South Temple
Suite 150
Salt Lake City
UT
UTAH
84102
Executive Officer
Mark
V
Anderson
757 East South Temple
Suite 150
Salt Lake City
UT
UTAH
84102
Executive Officer
Robin
L
Smith
757 East South Temple
Suite 150
Salt Lake City
UT
UTAH
84102
Director
Robert
W
Raybould
757 East South Temple
Suite 150
Salt Lake City
UT
UTAH
84102
Director
Todd
M
Morgan
757 East South Temple
Suite 150
Salt Lake City
UT
UTAH
84102
Director
John
C
Ruckdeschel
757 East South Temple
Suite 150
Salt Lake City
UT
UTAH
84102
Director
J
Scott
Nixon
757 East South Temple
Suite 150
Salt Lake City
UT
UTAH
84102
Director
Neil
Berkley
757 East South Temple
Suite 150
Salt Lake City
UT
UTAH
84102
Director
Biotechnology
Decline to Disclose
- 06c
false
2018-03-01
false
true
true
true
false
25000
Weild & Co.
132398
None
None
777 29TH STREET
SUITE 402
BOULDER
CO
COLORADO
80303
AZ
ARIZONA
CA
CALIFORNIA
CO
COLORADO
CT
CONNECTICUT
DE
DELAWARE
DC
DISTRICT OF COLUMBIA
FL
FLORIDA
GA
GEORGIA
ID
IDAHO
IL
ILLINOIS
KY
KENTUCKY
LA
LOUISIANA
MA
MASSACHUSETTS
MN
MINNESOTA
MT
MONTANA
NV
NEVADA
NJ
NEW JERSEY
NY
NEW YORK
NC
NORTH CAROLINA
OH
OHIO
OR
OREGON
PA
PENNSYLVANIA
TX
TEXAS
UT
UTAH
VA
VIRGINIA
WA
WASHINGTON
WY
WYOMING
false
3000000
824000
2176000
false
4
300000
true
0
Fee to broker is 10% of cash proceeds, plus a warrant to purchase 10% of conversion shares.
0
true
false
PROLUNG INC
/s/ Mark V. Anderson
Mark V. Anderson
Chief Financial Officer
2018-03-16